Top View
- When Do We Get to Bmps? (And Which Bmps Do We Have in Mind?)
- 2002 Annual Report Three Years in Brief–Worldwide
- Johnson & Johnson
- Annual Report: 2017
- ICN Vertical Mergers Survey Report
- Evidence Tables
- CONCERTA Safely and Effectively
- Investor Relations Business Overview Q3 2011
- Case No COMP/M.4314 - JOHNSON & JOHNSON / PFIZER CONSUMER HEALTHCARE
- FY07 Pharmaceutical Marketing Disclosures Report
- Trade Name Generic Name Forms Strength Category Registration NO
- Filed by Johnson & Johnson Pursuant to Rule 425
- Johnson & Johnson and Pfizer Consumer Healthcare
- Appendix 4: Detail Expenditures by Sponsor (Award Categories) Sponsor Name FY14 Exp
- Pre-2973 MDL Case Management Order #5
- Johnson & Johnson 2005 Annual Report
- 1:20-Cv-03471 Document #: 370 Filed: 02/03/21 Page 1 of 27 Pageid #:27504
- UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C
- 4101 105 CMR 720.000: LIST of INTERCHANGEABLE DRUG PRODUCTS Section 72
- 2020 Annual Report • • Failure to Meet Compliance Obligations in the Mcneil-PPC, Inc
- Why Give? Mississippi State University Foundation ANNUAL REPORT 2009-2010
- IR General Presentation
- Evidence Tables
- Intentional Abuse 2011 Startdate Casenumbeexpreason
- Registered Drug Distribution Agents, Manufacturers Wholesalers As of 2/19/21
- List of Drugs Registered in Accordance with the Provisions of the Food and Drugs Act and Regulations Chapter 30:01
- EXHIBIT 21 SUBSIDIARIES Johnson & Johnson, a New Jersey
- 2012 ANNUAL REPORT This Year We’Ve Created a Fully Interactive, Digital, Online Annual Report Where You Can Find Our Stories of Caring
- Medicines and Related Substances Act, 1965 (Act 101 of 1965)
- In This Issue
- ORTHO-MCNEIL : PHARMACEUTICAL, INC., : : Plaintiff and : Counterclaim Defendant, : CIVIL ACTION NO.: 02-5707 (JCL) : V
- Reaching More Serving More Health Needs